Company Overview
Company Name
Alexion Pharmaceuticals, Inc.
Address
801 Pennsylvania Avenue NW #830, Washington, DC, 20004, United States
Website
alexion.comPhone
(202) 688-6650Approx. Annual Revenue
$1400.0M
Employees
1,001
About Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is a company headquartered in Washington, DC, United States, with approximately 1,001 employees. The company is dedicated to delivering life-changing therapies to people living with rare diseases, focusing on research, development, and innovation in areas such as bone metabolism, cardiology, endocrinology, and more.
Frequently Asked Questions about Alexion Pharmaceuticals, Inc.
Technologies Used
Social Profiles
Key Decision Makers
Chris Johnson Executive Director, Head of U.S. Sales
Ron Gugliotti Director of Clinical Development
Sahar Esteghamat, MSc, PhD Director-Clinical Development Scientist
Ghaith Mitri Sr. Medical Director, Clinical Development, Rheumatology & Rare Diseases - Neurology & Ophthalmology
Disha Patel Clinical Trial Manager - II
Theodore Wing Senior Clinical Research Associate
Sharitta Cuttino Senior Clinical Research Associate
Thema Marie V. Sr. Clinical Research Associate
Ashwan Errawalla Clinical Trial Manager
Elizabeth Buckley Clinical Trial Manager
Cesar Delcompare Clinical Trial Manager II
Yikun Guo Clinical Trial Manager II